Skip to content

Aurion Biotech vs StemSight - Vision Unlimited

Aurion Biotech logo

Aurion Biotech

We're on a mission to cure blindness with our transformational platform of advanced therapies

94 employees · est. 2022 · Seattle, United States

VS
StemSight - Vision Unlimited logo

StemSight - Vision Unlimited

Curing blindness with regenerative cell therapies

16 employees · est. 2021 · Tampere, Finland

StemSight - Vision Unlimited is the older company (2022 vs 2021); Aurion Biotech is the larger of the two.

Side-by-Side Comparison

Aurion Biotech StemSight - Vision Unlimited
Founded
2022 2021 older
Headquarters
Seattle, United States Tampere, Finland
Employees
94 larger 16
Industry
Biopharma, Biotechnology, Health Care Biotechnology, Health Care, Health and Wellness
Funding Stage
Acquired Seed
Total Funding
$120.00M $2.80M
Funding Rounds
2 2
Services
Development of cell therapy treatments, Clinical trial execution, Regulatory and quality management, Manufacturing advanced therapies Not tracked yet
Target Customers
Patients with corneal endothelial diseases, Ophthalmologists, Healthcare providers specializing in vision care, Clinical researchers Not tracked yet
Taxonomy
BiotechClinical StageAdvanced TherapiesCorneal Endothelial DiseaseCell TherapyBiomedical +8 Regenerative MedicineCell TherapyCorneal BlindnessStem CellsIPS-Derived CellsBiomaterials +3
Website
aurionbiotech.com stemsight.fi
Aurion Biotech logo

About Aurion Biotech

Aurion Biotech, founded in 2022, is a promising clinical-stage biotech company, headquartered in the United States, with a clear mission embodied in its slogan: "We're on a mission to cure blindness with our transformational platform of advanced therapies." Specializing in biopharma and biotechnolo...

StemSight - Vision Unlimited logo

About StemSight - Vision Unlimited

StemSight is a biotechnology startup based in Finland, founded in 2021. The company's slogan, "Curing blindness with regenerative cell therapies," encapsulates its mission to develop off-the-shelf regenerative cell therapies for corneal blindness. StemSight's innovative approach involves the combina...

Also comparing in this category

Comparing more than these two?

Get Aurion Biotech, StemSight - Vision Unlimited and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Aurion Biotech compare?

A PDF of Aurion Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Aurion Biotech was founded in 2022, based in Seattle, United States, with 94 employees. Aurion Biotech, founded in 2022, is a promising clinical-stage biotech company, headquartered in the United States, with a clear mission embodied in its slogan: "We're on a mission to cure blindness w. StemSight - Vision Unlimited was founded in 2021, based in Tampere, Finland, with 16 employees. StemSight is a biotechnology startup based in Finland, founded in 2021. The company's slogan, "Curing blindness with regenerative cell therapies," encapsulates its mission to develop off-the-shelf reg.
Aurion Biotech has raised $120.00M and StemSight - Vision Unlimited $2.80M. Latest stage: Aurion Biotech Acquired, StemSight - Vision Unlimited Seed.
Both work in Biotechnology and Health Care and list cell therapy and regenerative medicine among their focus areas.

Compare Aurion Biotech with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Aurion Biotech on 11 Sep 2024, and StemSight - Vision Unlimited on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout